peptide laws FAQ

Contact your supplier immediately to verify all documentation was included with the shipment. Customs officers detain peptide imports primarily when documentation is incomplete or contradictory. Missing certificates of analysis, vague product descriptions on invoices, or labelling that suggests human use. Real Peptides includes pre-clearance documentation with every UK-bound order, but if customs requests additional verification, the supplier can provide manufacturing records, GMP certifications, and clarification letters directly to customs officials. Detention typically resolves within 5–7 business days once proper documentation is submitted.

UK peptide laws don't require institutional affiliation for research peptide imports, but customs officers may request evidence of legitimate research intent if you're importing as an individual. This can include documentation of a registered home laboratory, correspondence with academic collaborators, or records of published research involving peptides. Real Peptides recommends individual researchers maintain a research log or project documentation that can be provided to customs if questioned. The key compliance factor isn't where you work. It's proving the peptides are for non-human research, not personal therapeutic use.

Structural identity to a pharmaceutical compound doesn't automatically prohibit research peptide sourcing. Tirzepatide, semaglutide, and other GLP-1 receptor agonists are legal to import as research-grade peptides when purchased without therapeutic marketing claims. The MHRA focuses on intended use, not molecular structure. Purchase from a supplier that labels the peptide for research only, includes batch documentation, and avoids any language suggesting human therapeutic application. If your research involves compounds on the controlled substances list (very few peptides qualify), verify import requirements with MHRA before ordering.

Contact the Australian Border Force office listed on the seizure notice within 30 days to request a review. Provide documentation proving research intent: institutional affiliation, ethics approval, or Section 19 permit application evidence. If you can demonstrate the peptide was ordered for legitimate research and you were unaware of permit requirements, ABF may release the shipment with a formal warning. If documentation is absent or the peptide is Schedule 4 without authorisation, the shipment is destroyed and you receive a compliance letter. Repeated violations trigger TGA enforcement action including fines up to $13,320 per offence under Section 21 of the Therapeutic Goods Act.

Not for in vitro research using cell cultures or biochemical assays. Ethics approval is required only if your research protocol involves human participants or animal subjects. However, institutional affiliation is always required. The TGA will not grant Section 19 permits to individuals without documented connection to a registered research institution, university, or hospital. If you're an independent researcher, affiliate with a university as a visiting researcher or honorary associate before applying.

No. Unscheduled status means it's not on the Poisons Standard, but peptide laws australia TGA regulations still classify it as a therapeutic good if it has biological activity. Section 19 import permits are strongly recommended for all peptides regardless of scheduling. Customs officers don't verify Poisons Standard classifications at the border. They flag peptide shipments generally and refer them to TGA compliance for assessment. Importing without a permit and receiving a compliance notice creates a regulatory file that complicates future legitimate applications.